Literature DB >> 30460542

SACS variants are a relevant cause of autosomal recessive hereditary motor and sensory neuropathy.

Katharina Vill1, Wolfgang Müller-Felber2, Dieter Gläser3, Marius Kuhn3, Veronika Teusch4,5, Herbert Schreiber6, Joachim Weis7, Jörg Klepper8, Anja Schirmacher9, Astrid Blaschek2, Manuela Wiessner10, Tim M Strom11, Bianca Dräger9, Kristina Hofmeister-Kiltz12, Moritz Tacke2, Lucia Gerstl2, Peter Young9, Rita Horvath13, Jan Senderek10.   

Abstract

Mutations in the SACS gene have been initially reported in a rare autosomal recessive cerebellar ataxia syndrome featuring prominent cerebellar atrophy, spasticity and peripheral neuropathy as well as retinal abnormalities in some cases (autosomal recessive spastic ataxia of Charlevoix-Saguenay, ARSACS). In the past few years, the phenotypic spectrum has broadened, mainly owing to the availability and application of high-throughput genetic testing methods. We identified nine patients (three sib pairs, three singleton cases) with isolated, non-syndromic hereditary motor and sensory neuropathy (HMSN) who carried pathogenic SACS mutations, either in the homozygous or compound heterozygous state. None of the patients displayed spasticity or pyramidal signs. Ataxia, which was noted in only three patients, was consistent with a sensory ataxia. Nerve conduction and nerve biopsy studies showed mixed demyelinating and axonal neuropathy. Brain MRI scans were either normal or revealed isolated upper vermis atrophy of the cerebellum. Our findings confirm the broad clinical spectrum associated with SACS mutations, including pure polyneuropathy without characteristic clinical and brain imaging manifestations of ARSACS.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30460542     DOI: 10.1007/s00439-018-1952-6

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  38 in total

Review 1.  Towards a functional pathology of hereditary neuropathies.

Authors:  Joachim Weis; Kristl G Claeys; Andreas Roos; Hamid Azzedine; Istvan Katona; J Michael Schröder; Jan Senderek
Journal:  Acta Neuropathol       Date:  2016-11-28       Impact factor: 17.088

2.  Early-onset axonal Charcot-Marie-Tooth disease due to SACS mutation.

Authors:  Paulo Victor Sgobbi Souza; Thiago Bortholin; Fernando George Monteiro Naylor; Wladimir Bocca Vieira de Rezende Pinto; Acary Souza Bulle Oliveira
Journal:  Neuromuscul Disord       Date:  2017-11-24       Impact factor: 4.296

3.  Diagnostic algorithms in Charcot-Marie-Tooth neuropathies: experiences from a German genetic laboratory on the basis of 1206 index patients.

Authors:  S Rudnik-Schöneborn; D Tölle; J Senderek; K Eggermann; M Elbracht; U Kornak; M von der Hagen; J Kirschner; B Leube; W Müller-Felber; U Schara; K von Au; D Wieczorek; C Bußmann; K Zerres
Journal:  Clin Genet       Date:  2015-04-29       Impact factor: 4.438

4.  A novel SACS mutation in an atypical case with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS).

Authors:  Satoko Miyatake; Noriko Miyake; Hiroshi Doi; Hirotomo Saitsu; Katsuhisa Ogata; Mitsuru Kawai; Naomichi Matsumoto
Journal:  Intern Med       Date:  2012-08-15       Impact factor: 1.271

5.  Mitochondrial abnormalities and intrafamilial variability of sural nerve biopsy findings in adrenomyeloneuropathy.

Authors:  J M Schröder; M Mayer; J Weis
Journal:  Acta Neuropathol       Date:  1996-07       Impact factor: 17.088

6.  Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15.

Authors:  Jan Senderek; Carsten Bergmann; Susanne Weber; Uwe-Peter Ketelsen; Hubert Schorle; Sabine Rudnik-Schöneborn; Reinhard Büttner; Eckhard Buchheim; Klaus Zerres
Journal:  Hum Mol Genet       Date:  2003-02-01       Impact factor: 6.150

7.  ARSACS in the Dutch population: a frequent cause of early-onset cerebellar ataxia.

Authors:  Sascha Vermeer; Rowdy P P Meijer; Benjamin J Pijl; Janneke Timmermans; Johannes R M Cruysberg; Maaike M Bos; Helenius J Schelhaas; Bart P C van de Warrenburg; Nine V A M Knoers; Hans Scheffer; Berry Kremer
Journal:  Neurogenetics       Date:  2008-05-09       Impact factor: 2.660

8.  Powerhouse failure and oxidative damage in autosomal recessive spastic ataxia of Charlevoix-Saguenay.

Authors:  Chiara Criscuolo; C Procaccini; M C Meschini; A Cianflone; R Carbone; S Doccini; D Devos; C Nesti; I Vuillaume; M Pellegrino; A Filla; G De Michele; G Matarese; F M Santorelli
Journal:  J Neurol       Date:  2015-11-03       Impact factor: 4.849

9.  Autosomal recessive spastic ataxia of Charlevoix Saguenay (ARSACS): expanding the genetic, clinical and imaging spectrum.

Authors:  Matthis Synofzik; Anne S Soehn; Janina Gburek-Augustat; Julia Schicks; Kathrin N Karle; Rebecca Schüle; Tobias B Haack; Martin Schöning; Saskia Biskup; Sabine Rudnik-Schöneborn; Jan Senderek; Karl-Titus Hoffmann; Patrick MacLeod; Johannes Schwarz; Benjamin Bender; Stefan Krüger; Friedmar Kreuz; Peter Bauer; Ludger Schöls
Journal:  Orphanet J Rare Dis       Date:  2013-03-15       Impact factor: 4.123

10.  A reduction in Drp1-mediated fission compromises mitochondrial health in autosomal recessive spastic ataxia of Charlevoix Saguenay.

Authors:  Teisha Y Bradshaw; Lisa E L Romano; Emma J Duncan; Suran Nethisinghe; Rosella Abeti; Gregory J Michael; Paola Giunti; Sascha Vermeer; J Paul Chapple
Journal:  Hum Mol Genet       Date:  2016-06-10       Impact factor: 6.150

View more
  8 in total

1.  Childhood-onset autosomal recessive ataxias: a cross-sectional study from Turkey.

Authors:  Hatice Mutlu-Albayrak; Emre Kırat; Gürkan Gürbüz
Journal:  Neurogenetics       Date:  2019-11-19       Impact factor: 2.660

2.  Bioinformatics-Based Identification of Expanded Repeats: A Non-reference Intronic Pentamer Expansion in RFC1 Causes CANVAS.

Authors:  Haloom Rafehi; David J Szmulewicz; Mark F Bennett; Nara L M Sobreira; Kate Pope; Katherine R Smith; Greta Gillies; Peter Diakumis; Egor Dolzhenko; Michael A Eberle; María García Barcina; David P Breen; Andrew M Chancellor; Phillip D Cremer; Martin B Delatycki; Brent L Fogel; Anna Hackett; G Michael Halmagyi; Solange Kapetanovic; Anthony Lang; Stuart Mossman; Weiyi Mu; Peter Patrikios; Susan L Perlman; Ian Rosemergy; Elsdon Storey; Shaun R D Watson; Michael A Wilson; David S Zee; David Valle; David J Amor; Melanie Bahlo; Paul J Lockhart
Journal:  Am J Hum Genet       Date:  2019-06-20       Impact factor: 11.025

Review 3.  A Proposed Diagnostic Algorithm for Inborn Errors of Metabolism Presenting With Movements Disorders.

Authors:  Juan Darío Ortigoza-Escobar
Journal:  Front Neurol       Date:  2020-11-13       Impact factor: 4.003

Review 4.  Genetics of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) and Role of Sacsin in Neurodegeneration.

Authors:  Jaya Bagaria; Eva Bagyinszky; Seong Soo A An
Journal:  Int J Mol Sci       Date:  2022-01-04       Impact factor: 5.923

5.  Genetic spectrum and clinical features in a cohort of Chinese patients with autosomal recessive cerebellar ataxias.

Authors:  Hao-Ling Cheng; Ya-Ru Shao; Yi Dong; Hai-Lin Dong; Lu Yang; Yin Ma; Ying Shen; Zhi-Ying Wu
Journal:  Transl Neurodegener       Date:  2021-10-18       Impact factor: 8.014

Review 6.  Documenting manifestations and impacts of autosomal recessive spastic ataxia of Charlevoix-Saguenay to develop patient-reported outcome.

Authors:  Marjolaine Tremblay; Laura Girard-Côté; Bernard Brais; Cynthia Gagnon
Journal:  Orphanet J Rare Dis       Date:  2022-10-01       Impact factor: 4.303

Review 7.  The Intersection Between Cerebellar Ataxia and Neuropathy: a Proposed Classification and a Diagnostic Approach.

Authors:  Cristina Saade Jaques; Marcio Luiz Escorcio-Bezerra; José Luiz Pedroso; Orlando Graziani Povoas Barsottini
Journal:  Cerebellum       Date:  2021-08-09       Impact factor: 3.847

8.  SACS Gene Deletional Mutation Presenting as an Isolated Nonprogressive Sensory Motor Axonal Neuropathy: A Case Report.

Authors:  Vikash Agarwal; Dinesh Nayak; Anil Venkatachalam; Haseeb Hasan
Journal:  Ann Indian Acad Neurol       Date:  2021-04-28       Impact factor: 1.383

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.